Yang Luo
@y-luo.bsky.social
Group Leader @OxfordUni working on MHC, immune-mediated traits, multi-ancestry and omics studies
Congratulations Lino!
September 10, 2025 at 9:40 PM
Congratulations Lino!
🙏 Huge thanks to @EstherNg (lab's first postdoc!) for her incredible work, and to @bpfairfax.bsky.social for a fantastic collaboration.
Working with open, brilliant scientists is always a joy — I learned so much about cancer immunology! 😊
Working with open, brilliant scientists is always a joy — I learned so much about cancer immunology! 😊
July 28, 2025 at 10:09 AM
🙏 Huge thanks to @EstherNg (lab's first postdoc!) for her incredible work, and to @bpfairfax.bsky.social for a fantastic collaboration.
Working with open, brilliant scientists is always a joy — I learned so much about cancer immunology! 😊
Working with open, brilliant scientists is always a joy — I learned so much about cancer immunology! 😊
🔍 As expected, the strongest trans-regulation of TCRs occurs in the MHC region.
What’s interesting 🤨 is that HLA-associated V genes were less stable across treatment. Notably, patients with HLA-regulated TCR clones showed improved overall survival.
What’s interesting 🤨 is that HLA-associated V genes were less stable across treatment. Notably, patients with HLA-regulated TCR clones showed improved overall survival.
July 28, 2025 at 10:09 AM
🔍 As expected, the strongest trans-regulation of TCRs occurs in the MHC region.
What’s interesting 🤨 is that HLA-associated V genes were less stable across treatment. Notably, patients with HLA-regulated TCR clones showed improved overall survival.
What’s interesting 🤨 is that HLA-associated V genes were less stable across treatment. Notably, patients with HLA-regulated TCR clones showed improved overall survival.
🧬 In this study, we analysed the genetic regulation of CD8+ TCRs in 250 cancer patients, before and after ICB treatment.
July 28, 2025 at 10:09 AM
🧬 In this study, we analysed the genetic regulation of CD8+ TCRs in 250 cancer patients, before and after ICB treatment.